SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is seeing explosive, trend-driven momentum fueled by a combination of strong AI-related memory demand, a pending Nasdaq-100 index inclusion, and aggressive analyst price target hikes. While the community is sharply divided between those riding the parabolic surge and those warning of a potential blow-off top, active discussions remain heavily focused on the stock's massive year-over-year gains, high-stakes institutional flows, and the upcoming quarterly earnings report.

Maulcoin

Maulcoin is capturing attention as the community rallies behind its grassroots development and ambitious long-term goals, with supporters actively pushing for increased social media visibility and engagement. Investors are debating the project's staying power and potential for growth as they push toward new market capitalization milestones without traditional charting tools.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is currently experiencing significant market volatility driven by a collision between political endorsements and aggressive short-selling campaigns. Investors are intensely debating the firm's defense-sector dominance and long-term valuation, with active discussions focused on whether recent price action represents a temporary selloff or a fundamental repricing of AI-integrated defense stocks.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending as investors remain polarized over its role in the era of agentic AI, with bulls highlighting the company's strong cash position and enterprise orchestration capabilities while bears express concerns about competition and growth deceleration. Community discussions are heavily focused on the stock's recent price volatility and whether current valuation levels present a value opportunity or a long-term trap.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is seeing heavy retail and institutional volume, driven by investor excitement over its electro-optic polymer technology and recent foundry partnerships, including with Tower Semiconductor. The community is actively debating the stock's long-term potential as a critical component for AI data centers while closely monitoring the high level of short interest and recurring insider selling.

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing significant market interest and extreme volatility, driven by recent expansion news regarding the World Liberty Financial USD1 token and aggressive community-led hype. While supporters point to upcoming festival partnerships and a unique event-based utility model, the asset is also facing heavy skepticism from traders warning of potential pump-and-dump dynamics and high valuation risks.

Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.

Organon & Co.

Organon & Co. is trending as investors digest speculation surrounding a potential buyout, with community discussion intensely focused on whether a binding offer from Sun Pharma will materialize to unlock value. Despite management's denials, high volume and bullish sentiment persist, as traders weigh the company's debt load against its long-term potential as a standalone women's health play.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as a massive surge in investor confidence follows high-profile strategic partnerships with industry giants like Google and Tesla-linked Terafab. The community remains deeply divided between long-term bulls betting on a foundational turnaround in the AI infrastructure and foundry sector, and skeptics who are bracing for a pullback after a rapid, momentum-driven climb to multi-year highs.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares is currently trending as traders aggressively debate whether the recent surge in semiconductor stocks is a sustainable rally or a temporary bull trap driven by geopolitical volatility and market manipulation. Community sentiment is deeply polarized, with many participants actively swing trading the intense volatility and discussing the potential for further semiconductor sector corrections.

FIGHT

FIGHT is experiencing significant community buzz driven by speculative degen hype and association with trending meme coin movements. While some participants view the asset as a potential breakout play, others are debating the project's legitimacy and political associations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vera Therapeutics (NASDAQ:VERA) Stock Price Up 7.1% - What's Next?

Vera Therapeutics (NASDAQ:VERA) Trading Up 7.1% - Here's What Happened...

JPMorgan Chase & Co. Sells 228,182 Shares of Vera Therapeutics, Inc. $VERA

JPMorgan Chase & Co. cut its position in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 73.5% in the third quarter, according to the company in its most recent disclosure with the...

E. Ohman J or Asset Management AB Invests $2 Million in Vera Therapeutics, Inc. $VERA

E. Ohman J or Asset Management AB purchased a new stake in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) during the fourth quarter, according to the company in its most recent 13F...

Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of "Moderate Buy" by Brokerages

Shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the twelve brokerages that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, one has given a hold rating and...

This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year

Key PointsIntegral Health bought 100,000 Vera Therapeutics shares for an estimated $3.55 million in the fourth quarter...

Hudson Bay Capital Management LP Raises Holdings in Vera Therapeutics, Inc. $VERA

Hudson Bay Capital Management LP lifted its stake in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 47.4% during the 3rd quarter, according to the company in its most recent filing with the...

Algert Global LLC Acquires 39,235 Shares of Vera Therapeutics, Inc. $VERA

Algert Global LLC lifted its holdings in Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 15.4% in the third quarter, according to the company in its most recent 13F filing with the Securities...

This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment

Key PointsEversept Partners added 264,468 shares of Vera Therapeutics in the fourth quarter; the estimated transaction value was $9.39 million based on quarterly average pricing...

HighVista Strategies LLC Increases Position in Vera Therapeutics, Inc. $VERA

HighVista Strategies LLC increased its holdings in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 125.3% during the 3rd quarter, according to the company in its most recent 13F...

Vera Therapeutics, Inc. $VERA Shares Sold by First Light Asset Management LLC

First Light Asset Management LLC decreased its holdings in shares of Vera Therapeutics, Inc. (NASDAQ:VERA - Free Report) by 9.9% in the 3rd quarter, according to the company in its most recent...

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

VERA
Vera Therapeutics Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VERA News

VERAVera Therapeutics Inc - Ordinary Shares - Class A